Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Newborn Implementation

Not Applicable

Completed

Conditions: Language Development

Interventions: Behavioral: Thirty Million Words Initiative Newborn Intervention

First Posted Date: 2017-12-08

Last Posted Date: 2023-05-10

Lead Sponsor: University of Chicago

Target Recruit Count: 2701

Registration Number: NCT03366831

Locations: 🇺🇸
Sacred Heart Hospital, Pensacola, Florida, United States
🇺🇸
Baptist Hospital, Pensacola, Florida, United States
🇺🇸
TMW Center for Early Learning + Public Health at the University of Chicago Medicine, Chicago, Illinois, United States

A Study to Determine if Caffeine Accelerates Emergence From Propofol Anesthesia

Phase 4

Completed

Conditions: Anesthesia

Interventions: Drug: Placebo
Drug: Caffeine

First Posted Date: 2017-12-04

Last Posted Date: 2019-11-18

Lead Sponsor: University of Chicago

Target Recruit Count: 8

Registration Number: NCT03360903

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors

Phase 2

Suspended

Conditions: Thyroid Cancer
Salivary Gland Cancer

Interventions: Drug: Pembrolizumab
Drug: Docetaxel

First Posted Date: 2017-12-04

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 46

Registration Number: NCT03360890

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Tolcapone in Obsessive Compulsive Disorder

Phase 2

Completed

Conditions: Obsessive-Compulsive Disorder

Interventions: Drug: Tolcapone 200 MG

First Posted Date: 2017-11-21

Last Posted Date: 2022-04-07

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT03348930

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Implants on Mobile Health Unit

Completed

Conditions: Contraception

Interventions: Device: Nexplaon

First Posted Date: 2017-11-20

Last Posted Date: 2023-05-06

Lead Sponsor: University of Chicago

Target Recruit Count: 1

Registration Number: NCT03347539

Locations: 🇺🇸
The University of Chicago Medicine, Chicago, Illinois, United States

Mechanism of Action of Ocrelizumab in Multiple Sclerosis

Conditions: Immune System Diseases
Multiple Sclerosis

Interventions: Drug: ocrelizumab

First Posted Date: 2017-11-17

Last Posted Date: 2017-11-17

Lead Sponsor: University of Chicago

Target Recruit Count: 30

Registration Number: NCT03344094

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Selumetinib and Azacitidine in High Risk Chronic Blood Cancers

Phase 1

Recruiting

Conditions: Chronic Myeloid Leukemia
Myelofibroses

Interventions: Drug: Azacitidine
Drug: Selumetinib

First Posted Date: 2017-10-31

Last Posted Date: 2024-01-29

Lead Sponsor: University of Chicago

Target Recruit Count: 18

Registration Number: NCT03326310

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck

Phase 2

Withdrawn

Conditions: Squamous Cell Carcinoma of the Head and Neck

Interventions: Drug: Pembrolizumab
Drug: Epacadostat

First Posted Date: 2017-10-30

Last Posted Date: 2019-04-22

Lead Sponsor: University of Chicago

Registration Number: NCT03325465

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Automated Prediction and Prevention of Contrast Induced Nephropathy After Cardiac Catheterization

Completed

Conditions: Contrast-induced Nephropathy

Interventions: Other: Exposure to CBCIN risk score

First Posted Date: 2017-10-10

Last Posted Date: 2023-08-24

Lead Sponsor: University of Chicago

Target Recruit Count: 5

Registration Number: NCT03305874

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Feasibility of At-Home Handheld Spirometry

Not Applicable

Terminated

Conditions: COPD

Interventions: Device: SpiroPD

First Posted Date: 2017-09-15

Last Posted Date: 2023-05-31

Lead Sponsor: University of Chicago

Target Recruit Count: 8

Registration Number: NCT03284203

Locations: 🇺🇸
University of Chicago Medicine, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy